Jean-Jacques Bienaim
2012
In 2012, Jean-Jacques Bienaim earned a total compensation of $6.3M as Chief Executive Officer at BioMarin Pharmaceutical, a 67% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $994,367 |
|---|---|
| Option Awards | $2,353,400 |
| Salary | $821,052 |
| Stock Awards | $2,097,760 |
| Other | $22,503 |
| Total | $6,289,082 |
Bienaim received $2.4M in option awards, accounting for 37% of the total pay in 2012.
Bienaim also received $994.4K in non-equity incentive plan, $821.1K in salary, $2.1M in stock awards and $22.5K in other compensation.
Rankings
In 2012, Jean-Jacques Bienaim's compensation ranked 893rd out of 11,487 executives tracked by ExecPay. In other words, Bienaim earned more than 92.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 893 out of 11,487 | 92nd |
Division Manufacturing | 327 out of 4,252 | 92nd |
Major group Chemicals And Allied Products | 74 out of 1,200 | 94th |
Industry group Drugs | 40 out of 922 | 96th |
Industry Pharmaceutical Preparations | 36 out of 697 | 95th |
Source: SEC filing on April 23, 2015.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2012.
2012
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2012
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2012
Jeff Ajer
BioMarin Pharmaceutical
Senior Vice President, Chief Commercial Officer
2012
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019